Triflusal

DRUG5 trials

Sponsors

Gangnam Severance Hospital, Yonsei University, Prof. Dominique de Quervain, MD, University of Ioannina

Conditions

AtherothrombosisCerebral InfarctionHealthyVasospastic Syndrome

Phase 2

Influence of Triflusal on Cognitive Functions in Healthy Subjects

CompletedNCT02321852

Prof. Dominique de Quervain, MDHealthy

Start: 2015-01-31End: 2015-11-30Updated: 2015-11-10

Influence of Triflusal on Cognitive Functions in Subjects Under Chronic Stress

CompletedNCT02904109

Prof. Dominique de Quervain, MDHealthy

Start: 2016-09-13End: 2017-02-28Updated: 2017-03-01

Phase 4

Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping

CompletedNCT01174693

Gangnam Severance HospitalCerebral Infarction

Start: 2010-03-31End: 2015-03-31Updated: 2015-03-17

The Effect of Triflusal on Peripheral Microcirculation Dysfunction

CompletedNCT01612273

Yonsei UniversityVasospastic Syndrome

Start: 2011-04-30End: 2013-06-30Updated: 2014-03-05

ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)

CompletedNCT02616497

University of IoanninaAtherothrombosis

Start: 2015-09-30End: 2018-03-28Updated: 2018-04-17

Related Papers

Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial

Current Vascular Pharmacology2018-06-057 citations

Abstract TP411: Effects of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping

Stroke2017-02-011 citations

Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.

2016-01-053 citations